MicroRNA 409 (miR-409 (for mature forms, miR-409-3p/miR-409-5p); MIR409 (gene-level))

MicroRNA 409 (miR-409, gene: MIR409) is a non-coding RNA belonging to the microRNA family, located on human chromosome 14q32.31 and primarily functions as a post-transcriptional regulator of gene expression by binding to complementary sequences in target mRNAs and inhibiting their translation or promoting their degradation[5]. miR-409 is processed from a 79-base precursor to yield mature miR-409-3p and miR-409-5p strands, with the -3p form implicated in most reported biological and disease-related activities[3]. It plays critical roles in controlling cell migration, invasion, apoptosis, proliferation, and angiogenesis, with established involvement in various cancers (exerting either tumor suppressor or oncogenic effects depending on cell context)[2][3], neurodegeneration (e.g. modulating apoptosis in Parkinson’s disease models)[4], and other pathological states such as fibrosis and immune dysfunction[1]. As a regulatory RNA, miR-409 is being investigated as both a potential biomarker and a putative therapeutic target, but there are currently no approved drugs directed against it, and miRNA-based therapies face significant challenges in specificity, delivery, and safety[5].

Other names

hsa-mir-409MIRN409MIR409mir-409hsa-miR-409-3phsa-miR-409-5p

Not applicable (no approved or clinically studied drugs directly targeting miR-409); for experimental miRNA mimics/inhibitors: miRNA mimic: Upregulate miR-409 function to suppress target mRNAs; miRNA inhibitor/antagomir: Downregulate miR-409 function to de-repress target mRNAs